Patent details

Basic Information

Publication number:

EP3302440

PCT Application Number:

US2016035886

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167297399

PCT Publication Number:

WO2016197042

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED OR TARGETED RELEASE FORMULATIONS OF LINACLOTIDE

French Title of Invention:

FORMULATIONS À LIBÉRATION MODIFIÉE OU CIBLÉE DE LINACLOTIDE

German Title of Invention:

MODIFIZIERTE ODER GEZIELTE FREISETZUNGSFORMULIERUNGEN VON LINACLOTID

SPC Number:

Dates

Filing date:

03/06/2016

Grant date:

06/01/2021

EP Publication Date:

11/04/2018

PCT Publication Date:

08/12/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/01/2021

EP B1 Publication Date:

06/01/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/06/2021

Expiration date:

03/06/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/12/2020

 

 

Name:

Ironwood Pharmaceuticals, Inc.

Address:

100 Summer Street, Suite 2300, Boston, MA 02110, United States (US)

Inventor

Name:

HASHASH, Ahmad

Address:

United States (US)

Priority

1

Priority Number:

201562171462 P

Priority Date:

05/06/2015

Priority Country:

United States (US)

2

Priority Number:

201662339462 P

Priority Date:

20/05/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 9/28; A61K 38/10; A61P 1/00; A61P 13/10; A61P 29/02;

Publication

European Patent Bulletin

Issue number:

202101

Publication date:

06/01/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages